FDA gives full approval to Moderna COVID shot for at-risk kids

The Food and Drug Administration (FDA) on Thursday gave full approval to the modern Cov -19 vaccine for children, making it the first Kovid shot for children between 6 months to 11 years of age, which is no longer administered under the Emergency Use Authority.

Infants under 6 months are too short to vaccinate.

But the vaccine is available only to children with at least one underlying condition that puts them at high risk for serious consequences from Covid-19, the FDA said, Health Secretary Robert F. According to a change made by Kennedy Junior.

“Covid-19 has continued to pose an important potential threat to children, especially with underlying medical conditions.

Modern said that it expects its update vaccine available for the eligible population in the US for the 2025–2026 respiratory virus season.

The dose of modern and fizzle to the dosage is available to all children regardless of risk. But in May, Kennedy said that the Department of Health and Human Services will be there No recommendation now Koronwirus vaccine for healthy pregnant women or healthy children.

Following their announcement, the Center for Disease Control and Prevention recommended vaccines on the basis of “shared clinical decision making” between parents and their children’s provider.

But the new licensing stipulation can make it difficult for parents who want to vaccinate their healthy children against Kovid to do so, as it is now effectively an off-labeled use of the vaccine.

Earlier this week leads the major medical groups led by the American Academy of Pediatrics trial On new vaccine restrictions.

Source link

Please follow and like us:
Pin Share

Leave a Reply

Your email address will not be published. Required fields are marked *